Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

Wetteri Plc Press Release 31.3.2025 at 9:30 am EET Wetteri to provide Mazda sales and service services in Lahti Cooperation between Wetteri and Inchcape Motors Finland Oy is intensifying. The companie ...

International award ceremony to acknowledge the award winners Mitsui Chemicals Catalysis Science Awards were established by ...